(19)
(11) EP 1 546 122 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.05.2008 Bulletin 2008/22

(45) Mention of the grant of the patent:
21.11.2007 Bulletin 2007/47

(21) Application number: 03750599.7

(22) Date of filing: 22.09.2003
(51) International Patent Classification (IPC): 
C07D 257/04(2006.01)
(86) International application number:
PCT/EP2003/010543
(87) International publication number:
WO 2004/026847 (01.04.2004 Gazette 2004/14)

(54)

PROCESS FOR THE MANUFACTURE OF VALSARTAN

VERFAHREN ZUR HERSTELLUNG VON VALSARTAN

PROCEDE DE FABRICATION DU VALSARTAN

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 23.09.2002 GB 0222056

(43) Date of publication of application:
29.06.2005 Bulletin 2005/26

(60) Divisional application:
07113176.7 / 1878729

(73) Proprietors:
  • Novartis AG
    4056 Basel (CH)
    Designated Contracting States:
    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR 
  • Novartis Pharma GmbH
    1230 Wien (AT)
    Designated Contracting States:
    AT 

(72) Inventors:
  • DENNI-DISCHERT, Donatienne
    F-68000 Colmar (FR)
  • HIRT, Hans
    CH-4153 Reinach (CH)
  • NEVILLE, Dan
    CH-4052 Basel (CH)
  • SEDELMEIER, Gottfried
    79227 Schallstadt (DE)
  • SCHNYDER, Anita
    CH-4125 Riehen (CH)
  • DERRIEN, Nadine
    F-68330 Huningue (FR)
  • KAUFMANN, Daniel
    CH-4106 Therwil (CH)

(74) Representative: Morris, Clive Sydney et al
Corporate Intellectual Property Novartis AG
4002 Basel
4002 Basel (CH)


(56) References cited: : 
EP-A- 0 443 983
 US-A- 5 468 867
   
  • CRAMER ET AL.: "Prospective identification of biologically active structures by topomer shape similarity searching" J. MED. CHEM., vol. 42, 1999, pages 3919-3933, XP002149047
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).